Eighteen monoclonal antibodies (MAbs) directed against the purified human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) protein were produced. The antibodies were characterized by competitive ELISAs and Western blot experiments, and with nested, nine amino acid long peptides representing the whole 560 amino acid RT protein. By ELISA, the MAbs react with a minimum of seven epitopes of the protein. Four of the epitopes were located on the Nterminal 51K subunit and the remaining three epitopes were located at the C-terminal end of the protein.
Introduction
The polymerase (po/) gene of human immunodeficiency virus (HIV) encodes three proteins with enzymic activities. These proteins are an 18K protein with protease activity, a 66K reverse transcriptase (RT) protein and a 34K protein with endonuclease activity (Di Marzo Veronese et al., 1986; Lightfoote et al., 1986; Farmerie et al., 1987; Larder et al., 1987a, b; Mous et al., 1988; Hizi et al., 1990) . The 66K RT protein encoded by the middle portion of the pol gene consists of 560 amino acids and it has both RT and RNase H enzymic activities (Hizi et al., 1987 (Hizi et al., , 1990 Larder et al., 1987a, b; Le Grice et al., 1988) . The viral protease cleaves the 66K RT protein into an N-terminal 51K and a C-terminal 15K protein which are found in virions in equimolar amounts to the uncleaved 66K protein (Di Marzo Veronese et al., 1986; Farmerie et al., 1987; Lightfoote et al., 1986; Hansen et al., 1988; Mous et al., 1988; Ferris et al., 1990) . In Moloney murine leukaemia virus (MMLV), the RNA-dependent DNA polymerase activity and RNase H activity are located in the N and C termini of the protein, respectively, and sequence comparisons have shown that overall organization of HIV-1 RT is the same (Johnson et al., 1986;  0001-0138 © 1991 SGM Kotewicz et al., 1988; Tanese & Goff, 1988 ). Insertions and deletions in different parts of the pol gene of HIV demonstrate the same functional organization (Larder et al., 1987a (Larder et al., , b, 1989 Tisdale et al., 1988; Hizi et al., 1989 Hizi et al., , 1990 . However several mutations in the N and C termini of the protein abolish both enzymic activities (Larder et al., 1987a, b; Tisdale et al., 1988; Hizi et al., 1990) . For proper function, the whole protein is required for HIV whereas for MMLV the termini alone are sufficient to express their respective enzymic activities (Tanese & Goff, 1988; Hizi et al., 1990) .
Immunological and structural characterization has been carried out by the use of monoclonal antibodies (MAbs) directed against the RT protein of HIV (Di Matzo Veronese et al., 1986; Hansen et al., 1988; Tisdale et al., 1988; Ferris et al., 1990) . Tisdale et al. (1988) reported about eight MAbs against the protein; seven were directed against one epitope between amino acids 230 and 315, and the eighth antibody reacted with amino acids 531 to 539 at the C-terminal end of the protein.
None of these eight antibodies neutralize RT activity (Tisdale et al., 1988) . Ferris et al. (1990) described 11 MAbs reacting with three epitopes at the N terminus and two epitopes at the C terminus. Antibodies reacting with the N terminus precipitated both the 66K and 51K proteins, whereas antibodies reacting with the C terminus precipitated the 66K protein only. The small 15K protein cleavage product has been identified by an MAb directed against the C terminus of the protein (Hansen et al., 1988) .
The aim of the present study was to prepare a large number of MAbs against the RT protein of HIV-1 in order to map functional domains of the molecule.
Methods
Production ofhybridoma cell lines. The plasmid used to express HIV-1 RT and purification of the protein has been described (Unge et al., 1990) . One hundred micrograms of the 66K protein and the 51K and 15K subunits in a volume of 1 ml of PBS was mixed with an equal volume of Freund's complete adjuvant and 0-5 ml of the mixture was inoculated into each hind leg of young BALB/c mice. The procedure for booster immunization of the mice and for the establishment of mouse hybridoma cell lines have been described previously (Orvell & Grandien, 1982) , with the exception that the fusions were performed with the myeloma cell line SP 2/0.
ELISA.
As described previously (Orve|| & Grandien, 1982) , pure RT protein was diluted in PBS to a final protein concentration of 0' 1 gg in 100 gl and used to coat wells of plastic plates. Ascites material of individual hybridoma cell lines was diluted in 10-fold dilution steps. The highest 10-fold dilution giving an absorbance at 450 nm (A450) of more than 0.2 was considered as the end titre. ELISAs were also used to determine the Ig class and subclass of individual clones, as previously described (Orvell, 1984; Orvell et al., 1985) .
Western blot experiments. Forty micrograms of pure RT in 1 ml was boiled for 2 min in 1% SDS, 2% 2-mercaptoethanol, 10% glycerol and subjected to electrophoresis in 10% polyacrylamide gels (0.18 % N,N'-methylene-bisacrylamide) with a wide loading slot. Afterwards, polypeptides were transferred to nitrocellulose paper by electrophoresis at 100 V for 2 h in transfer buffer (0.19 M-glycine in 20% methanol). Next, nitrocellulose paper was soaked in 5 % dried milk powder in PBS for 30 rain at room temperature. Strips of 4 mm width were cut out and incubated at room temperature overnight with the ascites from individual hybridoma cell lines (final dilution 1 : 20) in ELISA dilution buffer (0-5% bovine serum albumin, 0.05% Tween 20 in PBS). The strips were washed three times in ELISA washing buffer (0.05 % Tween 20 in 0-9% NaCI) and peroxidase-labelled rabbit anti-mouse Ig (Dakopatts) was added (dilution l:500). After incubation at room temperature for 1 h, the strips were washed and developed with 5-aminosalicylate (5-AS).
Immunofluorescence (IF) analysis. The HTLV-IIIB strain of HIV-1 was grown in Molt-3 and H9 cells. At different times after infection, the cells were fixed in methanol:acetone (1:1) for 15 min at 4°C. The proportion of infected cells and the strength of the IF reactivity was investigated by comparison to a human reference serum. Ascites materials from each of the 18 clones were used at a dilution of 1 : 20 to stain the virus-infected cells. After incubation at 37 °C for 30 rain, the cells were washed in PBS and fluorescein-labelled goat anti-mouse Ig was added to the cells (dilution 1 : 20) . Following incubation at 37 °C for 30 min, the cells were washed, counterstained with Evans' blue and examined under a u.v. microscope.
Competition experiments using peroxidase-conjugated MAbs in ELISA.
The periodate method was used to conjugate horseradish peroxidase to ammonium sulphate-precipitated antibodies (Wilson & Nakane, 1978) . Unlabelled ascites material was allowed to compete with peroxidase-labelled antibodies on RT protein-coated plastic plates (protein concentration 1 gg/ml) as described previously (Orvell & Grandien, 1982; Orvell, 1984) . The highest 10-fold dilution of unlabelled clonal Ig that could reduce the A450 value caused by the labelled clonal Ig by 50% or more was considered to be the end titre.
Solid phase peptide synthesis and testing of the MAbs against the peptides by EL1SA. One hundred and forty-one nonapeptides overlapping by five amino acids representing the complete amino acid sequence of RT (HXB2 clone) were synthesized using an epitope scanning kit (Cambridge Research Biochemicals) based on multi-pin synthesis technology (Geysen et al., 1984) . A slight modification of the method described by Ohlin et al. (1991) was used. Prior to coupling the 9-fluorenylmethoxycarbonyl (Fmoc) ~-amino-protected amino acids were activated by use of 2-(1H-benzotriazol-l-yl)-l,l,3,3-tetramethyluronium tetrafluoroborate. The pins were reacted with individual antibodies of mouse ascites material diluted 1 : 50 in ELISA buffer at 37 °C for 1 h, followed by four washes in ELISA washing buffer. Peroxidase-labelled anti-mouse Ig (dilution 1 : 1000) was added at room temperature for 1 h and the pins were washed four times in washing buffer. The presence of peptide-bound antibody was detected by the substrate 5-AS and the A~5o was measured.
Inhibition of RT activity. The Ig produced by individual hybridoma cell lines was purified from mouse ascites and 0.5 ml of undiluted mouse ascites material was mixed with an equal volume of preswollen Protein G coupled to Sepharose (Pharmacia Fine Chemicals) and rocked at room temperature for 2 h. The Sepharose beads were washed four times in PBS and the antibodies were removed from the beads by two consecutive washes with 0-5 ml of 1 M-acetic acid. The eluted antibodies were dialysed against PBS to neutral pH and the protein content of the antibody preparations was estimated by the Lowry method. Purity of antibodies was assayed by PAGE and the pure antibody preparations were tested in an ELISA against the protein.
MAbs against respiratory syncytial (RS) virus (Orvell et al., 1987) were treated in the same way and used as controls.
A radioenzyme assay (Neumiiller et al., 1990 (Neumiiller et al., , 1991 Gronowitz et al., 1991) for the detection and quantification of HIV-I RT-inhibiting antibodies was used; this assay is now commercially available (Prolifivir RT i REA, Sangtec Medical Company). The enzyme inhibiting activity of the purified MAbs diluted in PBS was tested at protein concentrations of 10, 1, 0.1 and 0-01 ~tg/ml. Fifty D1 was mixed with an equal volume of enzyme in duplicate and the test-tube mixtures were incubated at 37 °C for 2 h. One-hundred microlitres of assay buffer (supplied by the manufacturer) was added to each test-tube and one plastic bead containing 125I-labelled enzyme substrate was added. After incubation at 37 °C for 3 h the reaction mixture was aspirated from the tubes and the beads were washed four times in PBS containing 0-5% Triton X-100. The wash fluid was aspirated away and the radioactivity associated with each bead was counted in a gamma counter. Antibody concentrations that could inhibit more than 50% of the activity of the control preparations (no antibody) were considered positive in the test. Two rabbit Ig preparations directed against purified RT with ability to inhibit 50 and 90%, respectively, of the activity of the control preparations (no antibody) were used as a positive reference antibody in the tests.
Results

Reactivity of MAbs against the recombinant RT protein in Western blot experiments
In two separate fusion experiments a total of 18 MAbs containing a significant titre in ELISA experiments with the recombinant protein were produced (Table 1) . In Western blot experiments 12 of these antibodies reacted 
Epitope mapping by competition experiments using peroxidase-conjugated MAbs against the N-and Cterminal parts of RT
From the Western blot experiments it was clear that 12 of the 18 antibodies reacted to epitopes contained within the first 440 N-terminal amino acids and five of the remaining six antibodies reacted to epitopes within the C terminus (amino acids 441 to 560). The topographical relationships between the binding sites were determined by competition experiments. Seven epitopes were identified on the protein (Tables 1 and 2 ). Competition experiments (Table 2) showed that the five antibodies reacting with the C-terminal part of the protein were directed against three epitopes: epitope 5 (MAb 996 E5), epitope 6 ( M A b 1.009 G9) and epitope 7 (MAbs 1. 158 El0, 1. 160 B3 and 1. 162 D10 
Immunofluorescence analysis
Four of the M A b s showed activity in I F experiments (Table 1) . Antibodies 1. 149 B6 and 1. 150 E2 (epitope 2) showed distinct IF activity when they were tested on H T L V -I I I B virus grown in Molt-3 or H9 cells. Antibody 1. 148 F2 (epitope 2) and anti'body 1. 152 B3 (epitope 3) were weakly positive in IF assays. * Titre of inhibition with inhibiting clone. This figure shows the highest 10-fold dilution of unlabelled clonal Ig that could inhibit 50~ or more of the binding of the peroxidase-conjugated antibody to the ELISA plate.
"[" -, No inhibiting of binding of peroxidase-conjugated clone. 
Analysis of binding of MAbs to synthetic peptides coupled to pins
Reproducible positive reactions were obtained with four MAbs, 1. 153 G10 (epitope 4), 1. 152 B3 (epitope 3), 1.158 E2 (epitope 3) and 1. 160 B3 (epitope 7)( Table 3 , Fig. 2 ). Antibodies 1. 152 B3 and 1. 158 E2 reacting with the same epitope in competition experiments reacted with the same peptide (amino acids 294 to 302). Antibody 1. 153 G10 (epitope 4) reacted with two overlapping peptides (amino acids 346 to 358; Table 3 , Fig. 2 ). Other antibodies reacting with epitopes 3 and 7 did not react with any synthetic peptide (see Discussion).
RT inhibition experiments using purified lg from individual MAbs
The purified Ig was diluted to a protein content of 10 gg per ml in ELISA dilution buffer and after that the antibodies were diluted in a lO-fold series and tested against the antigen by ELISA. All antibodies showed significant activity at an antibody concentration of 1 p~g per ml, but not at 0.1 ~tg per ml (Table 4) .
Two MAbs directed against the F protein of RS virus (Orvell et al., 1987) were used as negative control antibodies in the RT inhibition test; at a concentration of 10 I.tg/ml no inhibition was detected. Four of the 10 antibodies tested exhibited RT enzyme inhibitory activity. Antibodies reacting with epitope 3 could inhibit the enzyme at an Ig concentration of 0-1 and 1-0 ~g per ml, for antibodies 1. 152 B3 and 1. 158 E2, respectively. The inhibitory activity of antibody 1.152 B3 consistently inhibited 65~ of the enzyme at an antibody Ig concentration of 10, 1 and 0-1 ~tg per ml. The constant inhibitory activity of this antibody despite dilution is probably due to its presence at saturating concentrations at all three dilutions. Two other antibodies, 1. 149 B6 (epitope 2) and 1.009 G9 (epitope 6), could inhibit the activity of the enzyme at an Ig antibody concentration of 10 ~g per ml. These antibodies inhibited enzyme activity by 53 and 52~o, respectively.
Discussion
In the present study 18 MAbs reacting with the RT protein of HIV-1 were produced and characterized. The results of the binding studies with synthetic peptides corroborated those from Western blotting experiments in four cases. The exact location of the epitope recognized by t 3 antibodies reacting in Western blotting could not be defined in the ELISA tests; the reason for this is not known. Possibly the two tests have different sensitivities or antibodies may exist that are dependent on an antigenic configuration which is intact in Western blotting but not in the synthetic peptide. One antibody, 1. 153 G10 (epitope 4), reacted with two nested peptides with a common sequence from amino acids 350 to 354. It is therefore likely that this MAb binds to an epitope which at least partially spans both of these linear epitopes. This structure is well conserved among HIV-1 strains. Two antibodies belonging to epitope 3 were found to react with a peptide from amino acids 294 to 302, but a third antibody reacting with the same epitope did not react with this peptide. The latter antibody may possess the capacity to compete with the other antibodies by reacting with a structure adjacent to amino acids 294 to 302. Of the antibodies reacting with epitope 7, one antibody, 1. 160 B3, was found to react with amino acids 442 to 450, also conserved among HIV-1 strains.
It has recently been shown by site-directed mutagenesis that substitution of the conserved aspartic acid at position 443 by asparagine suppresses the RNase H activity of the protein without affecting the RT activity (Mizrahi et al., 1990 ). An insertion of five amino acids at position 444 for alanine, however, does not suppress RNase H activity (Prasad & Goff, 1989) . It would therefore be of interest to investigate which particular amino acids of the nonapeptide recognized by antibody 1. 160 B3 are required for binding and whether the antibody has the capacity to inhibit RNase H activity.
Although all 18 MAbs had a strong ELISA titre, only four exhibited positive IF reactivity. The strongest reactivity was found with antibodies reacting with epitope 2 located at the N-terminal part of the protein. A possible explanation for this result may be that some of the epitopes are exposed on the purified protein but not in infected cells. Alternatively, the fixation procedure may destroy the epitopes for some of these antibodies.
Two antibodies, 1. 152 B3 and 1. 158 E2, exhibited comparably high titres inhibiting the RT enzymic activity and two other antibodies exhibited a somewhat weaker inhibitory activity. Small insertions and substitutions in the area of amino acids 1 to 200 from the Nterminal part of the protein result in loss of RT activity in most cases and mutations beyond this region may also suppress RT activity (Hizi et al., 1989 (Hizi et al., , 1990 Larder et al., 1989; Prasad & Goff, 1989) . The antibodies with strongest RT inhibitory activity in the present study were located at amino acids 294 to 302. These antibodies could only inhibit 65~ of the enzymic activity, which may indicate that the antibodies did not recognize the active site of the enzyme. Incomplete blocking of enzymic activity may be due to steric hindrance exerted by the antibody on the binding of the enzyme to the template. An alternative explanation may be that the antibody binding to the protein will result in either configurational changes or restriction of conformational changes of the enzyme that may result in decreased activity. The latter explanation appears less probable, as the level of enzymic activity was constant with several dilutions of antibody.
In future experiments it would be of interest to create MAbs against preselected areas of the protein to see which antibodies would have a more pronounced effect on the enzyme activity. It would also be of interest to investigate whether the antibodies against the Cterminal part of the protein inhibit RNase H activity.
